In:
Biology, MDPI AG, Vol. 10, No. 12 ( 2021-12-08), p. 1296-
Abstract:
Glaucoma represents a group of chronic neurodegenerative diseases, constituting the second leading cause of blindness worldwide. To date, chronically elevated intraocular pressure has been identified as the main risk factor and the only treatable symptom. However, there is increasing evidence in the recent literature that IOP-independent molecular mechanisms also play an important role in the progression of the disease. In recent years, it has become increasingly clear that glaucoma has an autoimmune component. The main focus nowadays is elucidating glaucoma pathogenesis, finding early diagnostic options and new therapeutic approaches. This review article summarizes the impact of different antibodies and proteins associated with glaucoma that can be detected for example by microarray and mass spectrometric analyzes, which (i) provide information about expression profiles and associated molecular signaling pathways, (ii) can possibly be used as a diagnostic tool in future and, (iii) can identify possible targets for therapeutic approaches.
Type of Medium:
Online Resource
ISSN:
2079-7737
DOI:
10.3390/biology10121296
Language:
English
Publisher:
MDPI AG
Publication Date:
2021
detail.hit.zdb_id:
2661517-4
